Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Current and developing strategies

Authors:

Abstract
No abstract available
Funding Information
  • Eli Lilly and Company
  • Roche España
  • Eisai
  • Bristol-Myers Squibb

This publication has 201 references indexed in Scilit: